Literature DB >> 33692792

Interleukin-22 Influences the Th1/Th17 Axis.

Hannes Lindahl1, Tomas Olsson1.   

Abstract

Interleukin-22 (IL-22) is secreted by a wide range of immune cells and its downstream effects are mediated by the IL-22 receptor, which is present on non-immune cells in many organs throughout the body. IL-22 is an inflammatory mediator that conditions the tissue compartment by upregulating innate immune responses and is also a homeostatic factor that promotes tissue integrity and regeneration. Interestingly, the IL-22 system has also been linked to many T cell driven inflammatory diseases. Despite this, the downstream effects of IL-22 on the adaptive immune system has received little attention. We have reviewed the literature for experimental data that suggest IL-22 mediated effects on T cells, either transduced directly or via mediators expressed by innate immune cells or non-immune cells in response to IL-22. Collectively, the reviewed data indicate that IL-22 has a hitherto unappreciated influence on T helper cell polarization, or the secretion of signature cytokines, that is context dependent but in many cases results in a reduction of the Th1 type response and to some extent promotion of regulatory T cells. Further studies are needed that specifically address these aspects of IL-22 signaling, which can benefit the understanding and treatment of a wide range of diseases.
Copyright © 2021 Lindahl and Olsson.

Entities:  

Keywords:  animal models; infectious disease; inflammatory disease; interferon gamma; interleukin 17 (IL-17); interleukin 22 (IL-22)

Mesh:

Substances:

Year:  2021        PMID: 33692792      PMCID: PMC7937948          DOI: 10.3389/fimmu.2021.618110

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  108 in total

1.  Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.

Authors:  Yan Zheng; Dimitry M Danilenko; Patricia Valdez; Ian Kasman; Jeffrey Eastham-Anderson; Jianfeng Wu; Wenjun Ouyang
Journal:  Nature       Date:  2006-12-24       Impact factor: 49.962

2.  Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor.

Authors:  L Dumoutier; E Van Roost; D Colau; J C Renauld
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

3.  A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist.

Authors:  W Xu; S R Presnell; J Parrish-Novak; W Kindsvogel; S Jaspers; Z Chen; S R Dillon; Z Gao; T Gilbert; K Madden; S Schlutsmeyer; L Yao; T E Whitmore; Y Chandrasekher; F J Grant; M Maurer; L Jelinek; H Storey; T Brender; A Hammond; S Topouzis; C H Clegg; D C Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

4.  Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties.

Authors:  Eva Billerbeck; Yu-Hoi Kang; Lucy Walker; Helen Lockstone; Stefanie Grafmueller; Vicki Fleming; Jonathan Flint; Chris B Willberg; Bertram Bengsch; Bianca Seigel; Narayan Ramamurthy; Nicole Zitzmann; Eleanor J Barnes; Jonarthan Thevanayagam; Anisha Bhagwanani; Alasdair Leslie; Ye H Oo; Simon Kollnberger; Paul Bowness; Oliver Drognitz; David H Adams; Hubert E Blum; Robert Thimme; Paul Klenerman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-28       Impact factor: 11.205

5.  IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Authors:  Hak-Ling Ma; Spencer Liang; Jing Li; Lee Napierata; Tom Brown; Stephen Benoit; Mayra Senices; Davinder Gill; Kyriaki Dunussi-Joannopoulos; Mary Collins; Cheryl Nickerson-Nutter; Lynette A Fouser; Deborah A Young
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

6.  The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation.

Authors:  H Laaksonen; A O Guerreiro-Cacais; M Z Adzemovic; R Parsa; M Zeitelhofer; M Jagodic; T Olsson
Journal:  Genes Immun       Date:  2014-07-10       Impact factor: 2.676

7.  Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.

Authors:  Bruno Martin; Keiji Hirota; Daniel J Cua; Brigitta Stockinger; Marc Veldhoen
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

Review 8.  Therapeutic opportunities of the IL-22-IL-22R1 system.

Authors:  Robert Sabat; Wenjun Ouyang; Kerstin Wolk
Journal:  Nat Rev Drug Discov       Date:  2014-01       Impact factor: 84.694

9.  IL-22 is rapidly induced by Pathogen Recognition Receptors Stimulation in Bone-Marrow-derived Dendritic Cells in the Absence of IL-23.

Authors:  Silvia Fumagalli; Anna Torri; Angela Papagna; Stefania Citterio; Federica Mainoldi; Maria Foti
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

10.  Dual roles of IL-22 at ischemia-reperfusion injury and acute rejection stages of rat allograft liver transplantation.

Authors:  Yi Zhang; Xiaofei Wang; Liwei Mao; Di Yang; Weiwu Gao; Zhiqiang Tian; Mengjie Zhang; Xia Yang; Kuansheng Ma; Yuzhang Wu; Bing Ni
Journal:  Oncotarget       Date:  2017-12-15
View more
  4 in total

1.  Protective effects of interleukin-22 on oxalate-induced crystalline renal injury via alleviating mitochondrial damage and inflammatory response.

Authors:  Yuting Gu; Yilan Shen; Wei Chen; Haidong He; Yulei Ma; Xiaobin Mei; Dianwen Ju; Hongrui Liu
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-16       Impact factor: 4.813

Review 2.  Types of necroinflammation, the effect of cell death modalities on sterile inflammation.

Authors:  Anett Mázló; Viktória Jenei; Sára Burai; Tamás Molnár; Attila Bácsi; Gábor Koncz
Journal:  Cell Death Dis       Date:  2022-05-02       Impact factor: 9.685

Review 3.  Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.

Authors:  Long-Fang Chen; Cheng-De Yang; Xiao-Bing Cheng
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

Review 4.  Vitamin D, Th17 Lymphocytes, and Breast Cancer.

Authors:  Beata Filip-Psurska; Honorata Zachary; Aleksandra Strzykalska; Joanna Wietrzyk
Journal:  Cancers (Basel)       Date:  2022-07-27       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.